We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $3.16B
1-Year Est. Return 109.58%
This Fund
S&P 500
This Quarter Est. Return
+2.63%
1 Year Est. Return
+109.58%
3 Year Est. Return
+352.93%
5 Year Est. Return
+451.34%
10 Year Est. Return
+3,577.15%
AUM
$2.75B
AUM Growth
+$9.65M
Cap. Flow
+$34.6M
Cap. Flow %
1.26%
Top 10 Hldgs %
19.17%
Holding
309
New
22
Increased
110
Reduced
75
Closed
74

Top Buys

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$25.8M
2
FATE icon
Fate Therapeutics
FATE
+$13.9M
3
IMGO
Imago BioSciences, Inc. Common stock
IMGO
+$12.3M
4
STER
Sterling Check Corp. Common Stock
STER
+$10.8M
5
SKYT icon
SkyWater Technology
SKYT
+$9.26M

Top Sells

Rank Stock Value
1
AZEK
The AZEK Co
AZEK
+$19.8M
2
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
+$18.5M
3
SUM
Summit Materials, Inc. Class A Common Stock
SUM
+$17.9M
4
EVER icon
EverQuote
EVER
+$13M
5
ECHO
Echo Global Logistics, Inc.
ECHO
+$12.4M

Sector Composition

Rank Sector Weight
1 Technology 21.64%
2 Healthcare 20.11%
3 Consumer Discretionary 16.66%
4 Industrials 15.03%
5 Financials 13.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OC icon
176
Owens Corning
OC
$11.5B
$636K 0.02%
7,440
-359
-5% -$33.8K
KEYS icon
177
Keysight
KEYS
$54.5B
$627K 0.02%
3,819
+47
+1% +$7.89K
ADI icon
178
Analog Devices
ADI
$181B
$615K 0.02%
3,672
-178
-5% -$29.9K
AYX
179
DELISTED
Alteryx Inc
AYX
$593K 0.02%
8,109
-387
-5% -$29.1K
PANW icon
180
Palo Alto Networks
PANW
$264B
$591K 0.02%
7,398
+174
+2% +$12.2K
ALNY icon
181
Alnylam Pharmaceuticals
ALNY
$36.3B
$572K 0.02%
3,032
-1,057
-26% -$198K
ADBE icon
182
Adobe
ADBE
$89.5B
$571K 0.02%
992
– –
PEGA icon
183
Pegasystems
PEGA
$4.41B
$570K 0.02%
8,974
-410
-4% -$27.3K
IONS icon
184
Ionis Pharmaceuticals
IONS
$9.35B
$564K 0.02%
16,815
-806
-5% -$30.4K
CPAY icon
185
Corpay
CPAY
$24.2B
$553K 0.02%
2,118
-23
-1% -$5.95K
HD icon
186
Home Depot
HD
$332B
$537K 0.02%
1,636
– –
APH icon
187
Amphenol
APH
$188B
$515K 0.02%
14,054
-698
-5% -$25.6K
PLAN
188
DELISTED
Anaplan, Inc.
PLAN
$500K 0.02%
8,219
-394
-5% -$23.5K
STE icon
189
Steris
STE
$20.9B
$496K 0.02%
2,430
-13
-0.5% -$2.78K
LHX icon
190
L3Harris
LHX
$55.9B
$451K 0.02%
2,048
-18
-0.9% -$4.09K
PINS icon
191
Pinterest
PINS
$12.4B
$450K 0.02%
8,839
+2,346
+36% +$144K
MKTX icon
192
MarketAxess Holdings
MKTX
$4.15B
$449K 0.02%
1,067
+31
+3% +$14.2K
SPLK
193
DELISTED
Splunk Inc
SPLK
$448K 0.02%
3,099
-14
-0.4% -$2.04K
NKE icon
194
Nike
NKE
$61.9B
$447K 0.02%
+3,077
New +$502K
AQUA
195
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
$447K 0.02%
11,900
– –
CZNC icon
196
Citizens & Northern Corp
CZNC
$436M
$433K 0.02%
17,150
– –
EVER icon
197
EverQuote
EVER
$886M
$428K 0.02%
22,974
-545,162
-96% -$13M
BYRN icon
198
Byrna Technologies
BYRN
$80.3M
$398K 0.01%
+18,227
New +$451K
WST icon
199
West Pharmaceutical
WST
$23.1B
$395K 0.01%
930
– –
ZNGA
200
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$392K 0.01%
52,113
-2,765
-5% -$25.1K
6 7
8
9 10

Similar funds

FTUS
Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return
BFA
Bragg Financial Advisors Charlotte, North Carolina $3.16B AUM 26% 1-Year Est. Return
BP
BNP Paribas Paris, France $3.15B AUM 22.54% 1-Year Est. Return
CVA
Ceredex Value Advisors Orlando, Florida $3.18B AUM 35.23% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $3.18B AUM 23.46% 1-Year Est. Return
GKWIM
Gerber Kawasaki Wealth & Investment Management Santa Monica, California $3.14B AUM 22.62% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FAM
Foxhaven Asset Management Charlottesville, Virginia $3.19B AUM 12.34% 1-Year Est. Return

Emerald Advisers's Q3 2021 Portfolio in Review

As of Q3 2021, Emerald Advisers held 309 positions worth $2.75B, up 0.35% from $2.74B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Emerald Advisers's Q3 2021 filing shows 22 new, 110 increased, 75 reduced and 74 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 207,006 shares worth $28.8M. The largest sale was The AZEK Co, an estimated $19.8M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Emerald Advisers's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 207,006 shares worth $28.8M.
  • Emerald Advisers added most to SkyWater Technology in Q3 2021, an estimated $9.26M increase.
  • Emerald Advisers's biggest Q3 2021 reduction was EverQuote, cutting an estimated $13M.
  • Emerald Advisers fully exited The AZEK Co in Q3 2021, selling an estimated $19.8M.
  • Emerald Advisers's ten largest holdings make up 19% of its $2.75B portfolio in Q3 2021.
  • Emerald Advisers opened 22 new positions and closed 74 in Q3 2021.
  • Emerald Advisers's portfolio value rose 0.35% quarter-over-quarter to $2.75B.

Based on Emerald Advisers's 13F filing for Q3 2021, filed 28 Oct 2021.